Drug Shortage Report for TEGRETOL CR

Last updated on 2025-02-05 History
Report ID 245118
Drug Identification Number 00755583
Brand name TEGRETOL CR
Common or Proper name TEGRETOL CR 400MG TABS 100'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100'S
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-01-22
Actual start date
Estimated end date 2025-02-02
Actual end date 2025-02-04
Shortage status Resolved
Updated date 2025-02-05
Company comments Product on allocation to minimize patient impact.
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-02-05 French Compare
v9 2025-02-05 English Compare
v8 2025-01-23 English Compare
v7 2025-01-17 French Compare
v6 2025-01-17 English Compare
v5 2025-01-15 English Compare
v4 2024-12-19 French Compare
v3 2024-12-19 English Compare
v2 2024-12-09 French Compare
v1 2024-12-09 English Compare

Showing 1 to 10 of 10